Radiolabeled phosphonates have found widespread applications in nuclear medicine for the treatment of bone metastases. Even though considerable attention has been devoted to the administration of radiolabeled phosphonates to the patients, quality control (QC) studies belong to detection of them are still speculative and need to be improved. Herein, practical, efficient, and more reliable high-performance liquid chromatograpy (HPLC) methods were described for the first time. Radiochemical purity was easily determined by our developed analytical methods. N,N-Dimethylhexylamine and N,N-dimethyltetradecylamine were furnished as suitable ion pair reagents for the identification of radiopharmaceutical products. Effects of column type, pH of the mobile phase, and salt concentration were also examined.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jlcr.3972 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-bridged cyclam derivatives with bis(phosphinate) and phosphinate-phosphonate pendant arms (cb-BPC) as chelators for copper radioisotopes.
Org Biomol Chem
January 2025
Department of Inorganic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030, 128 40 Prague, Czech Republic.
Copper radioisotopes can be used for imaging as well as for therapy and, thus, can form ideal theranostic pairs. The Cu(II) complexes of cross-bridged cyclam (cb-cyclam) derivatives are considered to be highly stable . However, the complexes are mostly formed under harsh conditions not compatible with sensitive biomolecules.
View Article and Find Full Text PDFTowards Optimal Automated Ga-Radiolabeling Conditions of the DOTA-Bisphosphonate BPAMD Without Pre-Purification of the Generator Eluate.
J Labelled Comp Radiopharm
December 2024
Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
DOTA-functionalized bisphosphonates can be useful tools for PET imaging of bone metastases when radiolabeled with Ga. Moreover, the versatility of DOTA allows the complexation of radiometals with therapeutic applications (e.g.
View Article and Find Full Text PDFOctadentate Bispidine Chelators for Tb(III) Complexation: Pyridine Carboxylate versus Pyridine Phosphonate Donors.
Inorg Chem
December 2024
Equipe de Synthèse pour l'Analyse, Université de Strasbourg, CNRS, IPHC UMR 7178, Strasbourg F-67 087, France.
Article Synopsis
- Bispidine chelators are effective for creating stable metal complexes, and this study focuses on developing new terbium(III) complexes for medical imaging using bispidine-based ligands.
- The two synthesized complexes, differentiated by pyridine-phosphonate and picolinate subunits, exhibit distinct conformations and protonation schemes, affecting their stability and behavior.
- Notably, one complex shows remarkable kinetic inertness in various environments, retaining stability over extended periods, while also displaying bright luminescence, which is promising for imaging applications.
The Potential of Radiolabeled Bisphosphonates in SPECT and PET for Bone Imaging.
Curr Med Imaging
June 2024
Department of Pharmacy Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Selangor 43400, Malaysia.
Skeletal-related events due to bone metastases can be prevented by early diagnosis using radiological or nuclear imaging techniques. Nuclear medicine techniques such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have been used for diagnostic imaging of bone for decades. Although it is widely recognized that conventional diagnostic imaging techniques such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) have high sensitivity, low cost and wide availability, the specificity of both techniques is rather low compared to nuclear medicine techniques.
View Article and Find Full Text PDF68 Ga-DOTA-Ibandronic Acid PET/CT in a Patient With Chemotherapy-Induced Salivary Gland Hypofunction.
Clin Nucl Med
May 2024
General Medicine, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
DOTA-ibandronic acid (IBA) is a novel precursor targeting bone metastasis. It can be radiolabeled with 68 Ga for the diagnosis of bone metastases. However, extraosseous lesions can also show increased DOTA-IBA uptake.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!